(Q35946283)

11 August 2017

1 reference

title

Ontology-based knowledge management of troglitazone-induced hepatotoxicity (English)

1 reference

11 August 2017

0 references

1 reference

1 reference

Hubert Hug

1

1 reference

11 August 2017

Robert Dannecker

2

1 reference

11 August 2017

Richard Schindler

3

1 reference

11 August 2017

Dario Bagatto

4

1 reference

11 August 2017

André Stephan

5

1 reference

11 August 2017

Ralf Arno Wess

6

1 reference

11 August 2017

Joseph Gut

7

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

9

1 reference

11 August 2017

issue

22

1 reference

11 August 2017

page(s)

948-954

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Drug-induced hepatotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

1 reference

7 January 2021

Pharmacogenomics--drug disposition, drug targets, and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Inheritance and drug response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

ADRIS--The Adverse Drug Reactions Information Scheme

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Troglitazone-associated hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Mechanisms of troglitazone hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Indexing pharmacogenetic knowledge on the World Wide Web.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Promoting comparative molecular studies in environmental health research: an overview of the comparative toxicogenomics database (CTD).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

BIND: the Biomolecular Interaction Network Database

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Internet resources for proteins associated with drug therapeutic effects, adverse reactions and ADME.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

In vitro inhibition of phenolsulphotransferase by food and drink constituents

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Dietary (+)-catechin and BHT markedly increase alpha-tocopherol concentrations in rats by a tocopherol-omega-hydroxylase-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxicity to HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Pharmacogenetics: the ethical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

Corporate strategies for managing bioethical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903252-0

7 January 2021

10.1016/S1359-6446(04)03252-0

Identifiers

DOI

1 reference

11 August 2017

1 reference